Sandbox Reserved 1061

Structure of Mycobacterium Tuberculosis NrdH

spinqualitylabelsall models Micobacterium tuberculosis NrdH Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Overview Mycobacterium tuberculosis NrdH (MtNrdH) is a small glutaredoxin-like protein involved in the electron transport chain in ribonucleotide reduction. Therefore, it is extremely important in DNA production and replication because it helps supply cells with deoxyribonucleotides. Reduction of MtNrdH results in the breaking of an internal disulfide bond at the active site, allowing it to accept electrons and pass them on downstream. Due to its imperative role in ribionucleotide reduction, MtNrdH is thought to be essential to the reproductive integrity of M. tuberculosis, suggesting its role in infectivity and leading to its identification as a possible drug target. Background Mycobacterium tuberculosisresides in the lungs of a host. Upon becoming active, this bacterium results in a Tuberculosis infection (TB) and is the cause of symptoms such as chest pain, weakness, and intense coughing. Left untreated and unmanaged, TB can lead to death (1.5 million in 2013). The disease has a high co-morbidity with HIV/AIDS due to its immunocompromising tendencies. TB is one of the most heavily studied diseases today. With over 9 million infections worldwide per year, the necessity for antimicrobial agents to combat emerging multi-drug resistant strands is imperative. Structure The MtNrdH structure determined by x-ray crystallography has 79 residues in a single polypeptide chain. The active site (shown in green) is dominated by a disulfide bond between Cys-11 and Cys-14, which serves as the site of reduction by thioredoxin reductase. Many thioredoxin-like proteins have a similar active site region, which includes the thioredoxin fold, a large turn in the protein structure right before the disulfide bond. The residues directly following the fold, CVQC, are the most highly conserved of all areas of the protein across multiple species (Figure 1). Figure 1.Weblogo diagram showing highly conserved CVQC region of NrdH in four separate protein structures from Nocardia seriolae, E. coli, Cornebacterium Ammoniagenes, and Mycobacterium Tuberculosis. Conformational Changes Exactly how this structure relates to function is somewhat debated, but it is hypothesized that the fold allows residues preceding the turn to interact with the CVQC region after the turn. A threonine-7 reside directly across the thioredoxin fold from the disulfide bond has been suggested to adopt two different conformations which differently affect the redox abilities of the protein. In the "A" conformation, the alcohol oxygen of the threonine side chain (seen as a red ball) points towards the disulfide bond, forming an electrostatic interaction (represented by a short dashed line) between the two that prevents thioredoxin reductase (TrxR) from binding. Alternatively, in the "B" Conformation, the alcohol points in the opposite direction, allowing sufficient space and enough electrostatic freedom for the ligand to bind and reduction to occur. Figure 2.Hydrophobic region WSGFRP on the surface of MtNrdH (red) next to the active site (green.) Notice that this Hydrophobic region is heavily exposed to solvent. The WSGFRP sequence is thought to help thioredoxin reductase bind for reduction. The WSGFRP sequence, which is also highly conserved (Figure 3), is a nonpolar sequence that can be found on the surface of the molecule and is exposed to solvent (Figure 2). For this reason, it has been hypothesized that this sequence plays a role in the binding of thioredoxin reductase. Nonpolar residues on thioredoxin reductase would interact with the hydrophobic region, thus holding the thioredoxin reductase in place during reduction. Arg-68 is responsible for the stabilization of the hydrophobic region of NrdH. Arg-68 has two distinct conformations. In the first conformation, Arg-68 is hydrogen bonded to His- 60 and Asp-59. When Arg-68 shifts to its second conformation, it breaks its hydrogen bond with Asp-59. This reduction in hydrogen bonding gives the hydrophobic region more flexibility and is thought to occur when NrdH is in its inactive state. Figure 3.Weblogo diagram showing highly conserved WSGFRP region of NrdH in four separate protein structures from Nocardia seriolae, E. coli, Cornebacterium Ammoniagenes, and Mycobacterium Tuberculosis. Stabilization The active site of the protein is stabilized through a hydrogen bond network involving the two highly conserved series of residues, CVQC (green) and WSGFRP (red). A water molecule appears to be a key part of the H-bonding network. These hydrogen bonds orient the important residues in the most optimal position to promote oxidation and reduction. Function MtNrdH has been identified as an electron carrier protein in ribonuleotide reduction. Ribonucleotide reduction uses an enzyme called ribonucleotide reductase (RNR) to make deoxyribonucleotides, which act as precursors to DNA synthesis. Three classes of RNRs have been identified; each class differs in cofactor requirement, structure, and oxygen dependence, but the general catalytic mechanism is conserved in all three classes. Mycobacterium tuberculosis uses class I ribonucleotide reductase. Class I RNR is further subdivided into class Ia and Ib. Both Ia and Ib reduce ribonucleotide 5’ diphosphate to deoxyribonucleotide 5’ diphosphate (NDP to dNDP). Ribonucleotide reductase utilizes free thiols to reduce NDP to dNDP. After both of the free thiols give up their electrons, they form a disulfide bond. To be able to perform another round of reduction, the disulfide bond needs to be reduced into free thiols again. In class Ia, RNR is reduced by either glutadoxin or thioredoxin, which also use disulfide bonds and free thiols to pass electrons. In class Ib, RNR is reduced by NrdE, which is first reduced by NrdH (Figure 4). Like thioredoxin and glutadoxin, NrdE and NrdH both use a disulfide reduction mechanism (Figure 5). Thioredoxin reductase uses NADPH to reduce NrdH . An important distinction between Ia and Ib is that Ia is present in eukaryotes, eubacteria, bacteriophages, and virus, but Ib is only present in eubacteria. Figure 4.Ribonucleotide Reduction Class Ib general pathway. The role of NrdH is highlighted. Figure 5. The passing of electrons from NrdH to NrdE via disulfide reduction. . Relevance Like most NrdHs, MtNrdH is similar in sequence to glutaredoxins, but structurally similar to thioredoxins (Figure 6). MtNrdH also accepts electrons from thioredoxin reductase, a characteristic of thioredoxins, but not glutaredoxins. Figure 6.Structural comparison of NrdHs with "thioredoxin folds": E. Coli NrdH (green), C. ammoniagenes NrdH (blue), M. tuberculosis NrdH (red) Similar structures of NrdH have been isolated in other primitive species including E. coli, S. pyogenes, S. typhimurium, D. deserti, S. flexneri 2457T, S. dysenteriae, and C. glutamicium In higher order multi-cellular organisms, however, the NrdH protein is replaced by more complex glutaredoxins or thioredoxins. This observation leads some to speculate that NrdH is one of the very first ancestors in the ribonucleotide reduction pathway. If this is true, NrdH can be seen as a critical protein that allowed for the development of DNA-based life since deoxyribonucleotides could not have existed without the ribonucleotide reduction pathway. A better understanding of the evolutionary timeline of NrdH and similar proteins could shed greater light onto the RNA Wold Hypothesis, specifically describing the time frame of emergence of DNA based life. Possible Drug Target MtNrdH can serve as a potential drug target to treat tuberculosis. The genes encoding NrdE and NrdF2, a cofactor in class 1b ribonucleotide reduction, are essential for growth of M. tuberculosis in vitro. This suggests that M. tuberculosis relies solely on class Ib ribonucleotide reduction. If that is the case, NrdH may be an essential gene as well. Since NrdH is not found in humans, a drug that targets NrdH would be able to damage M. tuberculosis cells without hurting the human host.